featured news

Government Accountability Office Alerts Congress to Medicare & Medicaid Eligibility Issues

In fiscal year 2014, American taxpayers footed a $554 billion dollar bill for Medicare and Medicaid – two programs that, while essential in nature, are exceedingly strapped for resources. As one of the hallmark goals of the False Claims Act, authorities have worked diligently to ensure providers are billing correctly […]

D.C. Circuit Court Upholds ‘Implied Certification Theory’ in Recent False Claims Act Case

In yesterday’s post, we explored the concept of implied certification under the False Claims Act – a theory which somewhat eliminates the requirement for explicit false claims activity, but requires evidence that the defendant knew or should have known his activity did not comply with a government contract, but continued […]

Implied Certification Theory in False Claims Act Cases

A defendant may be liable under the False Claims Act on two different theories: the presentment of factually false claims and the presentment of legally false claims. A claim is factually false when a government payee submits information that is untrue on its face and misrepresents the goods or services […]

Federal Government Examines Helicopter Manufacturer Sikorsky Amid Allegations of Fraud

Aside from healthcare fraud, defense contractor fraud remains one of the top forms of waste and abuse addressed by the False Claims Act. Too often, big-budget defense contracts serve as fodder for dishonest companies to inflate and exaggerate costs, resulting in unnecessary spending of an already-strained defense budget. In one […]

Berger Montague Settles Whistleblower Lawsuit Involving AstraZeneca, Cephalon, & BioGen, Inc.; Secures $55 Million on Behalf of Taxpayers

As one of the leading and most successful whistleblower law firms in the United States, Berger Montague is pleased to announce its involvement in a $55.5 million settlement involving three major players in the pharmaceutical industry. This past July, Berger Montague announced the settlement against AstraZeneca, Cephalon, Inc., and BioGen, […]